Skip to content

A retrospective case-control study of lamotrigine in the treatment of dysesthesia in autism spectrum disorder

A retrospective case-control study of lamotrigine in the treatment of dysesthesia in autism spectrum disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071105
Enrollment
Unknown
Registered
2023-05-05
Start date
2022-09-03
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorders

Interventions

Traditional control group:N/A
Levetiracetam treatment group:N/A
Lamotrigine treatment group:N/A

Sponsors

Xi 'an Hospital of Traditional Chinese Medicine Encephalopathy / School of Basic Medical Sciences, Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.Patient population of children and adolescents of =15 years age with diagnosis of ASD as per DSM-IV 2.Patient was accompanied by epileptic symptoms. 3.Inpatient observation period for the retrospective case-control study was no less than 90 days. 4.Therapeutic effects were measured with the ABC and CARS scales and all records of hospitalization were complete.

Exclusion criteria

Exclusion criteria: 1.Population of children and adolescents or adults aged > 15 years diagnosed with ASD according to DSM-IV; 2.The patient did not have epilepsy symptoms; 3.The hospitalization observation period is less than 90 days; 4.The ABC and CARS scales were used to evaluate the treatment effect, and the hospitalization records were incomplete.

Design outcomes

Primary

MeasureTime frame
Childhood autism rating scale;

Secondary

MeasureTime frame
Autism behavior checklist;

Countries

China

Contacts

Public ContactNingxia Zhao / Shengxi Wu

Xi 'an Hospital of Traditional Chinese Medicine Encephalopathy / School of Basic Medical Sciences, Air Force Medical University

shengxi@fmmu.edu.cn+8618729228830 / +8613991121618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026